Refractory and Resistant Herpes Simplex Virus Mucocutaneous Infections in Immunocompromised Patients: Literature Review and Proposed Definitions for Use in Clinical Trials Journal Article


Authors: Chemaly, R. F.; Shafat, T.; Wald, A.; Kotton, C. N.; Papanicolaou, G.; Yong, M. K.; Miller, V.; Komatsu, T. E.; Mullick, C.; Hodowanec, A. C.; Westman, G.; Khawaja, F.; Birkmann, A.; Ljungman, P.; Forum, H. S. V. Resistance Working Grp Transplant Associated Viral Infections
Article Title: Refractory and Resistant Herpes Simplex Virus Mucocutaneous Infections in Immunocompromised Patients: Literature Review and Proposed Definitions for Use in Clinical Trials
Abstract: Herpes simplex virus (HSV) infection is one of the most prevalent viral infections worldwide. In general, host immunity is sufficient to clear viral shedding and recurrences, although it is insufficient to prevent subsequent virologic reactivations. In immunocompromised patients, prolonged and difficult-to-treat HSV infections may develop. The diagnosis of refractory HSV infection is based on the lack of clinical response to nucleoside analogs. Antiviral resistance is confirmed via genotypic and/or phenotypic testing. To provide consensus definitions of refractory and/or resistant (R/R) HSV mucocutaneous infections for clinical trial use, the HSV Resistance Working Group of the Transplant Associated Viral Infections Forum, which includes international clinicians, scientists, industry representatives, and regulatory officials, conducted a literature review of previously published data related to R/R HSV infections in immunocompromised patients. We propose definitions of R/R HSV mucocutaneous infections, which will be subject to re-evaluation and revision based on forthcoming data and future studies. The Herpes Simplex Virus (HSV) Resistance Working Group of the Transplant Associated Viral Infections Forum developed consensus definitions for resistant and refractory HSV infections in immunocompromised patients for use in clinical trials.
Keywords: thymidine kinase; herpes simplex virus; resistance; immunosuppression; double-blind; stem-cell transplantation; drug-resistance; refractory; definitions; antiviral drugs; long-term acyclovir; genital herpes; genotypic characterization; primase inhibitor bay-57-1293; dna-polymerase genes
Journal Title: Clinical Infectious Diseases
ISSN: 1058-4838
Publisher: Oxford University Press  
Publication status: Online ahead of print
Date Published: 2025-01-01
Online Publication Date: 2025-01-01
Language: English
ACCESSION: WOS:001407848700001
DOI: 10.1093/cid/ciae638
PROVIDER: wos
Notes: Review; Early Access -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics